Paion competitors

Paion Competitors include Amarin, Sucampo Pharmaceuticals, Array BioPharma and Amicus Therapeutics.
Add company...
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Amarin
Amarin
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.
Sucampo Pharmaceuticals
Sucampo Pharmaceuticals
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
2000
Founding Date
1991
Founding Date
1996
Founding Date
1998
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Aachen, DE HQ
Locations
Dublin, IE HQ
Bedminster Township, US
Locations
Rockville, US HQ
Sanda Shi, JP
Kita Ward, JP
Chuo Ward, JP
Chiyoda, JP
Zug, CH
Milton, GB
Locations
Boulder, US HQ
Miami, US
Boston, US
Phoenix, US
New York, US
Chicago, US
Houston, US
see more
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Employees
Employees
3218% decrease
Employees
24112% increase
Employees
139
Employees
209
Employees
263
Valuation ($)
Valuation ($)
185.3 m
Valuation ($)
5.6 b
Valuation ($)
1.2 b
Valuation ($)
3.7 b
Valuation ($)
2.3 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
242
Twitter followers
N/A
Twitter followers
793

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$181.1m (FY, 2017)
Revenue (est.)
$230.1m (FY, 2016)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
$36.9m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$45m (FY, 2017)
Cost of goods
$76m (FY, 2016)
Cost of goods
N/A
Cost of goods
$6.2m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
$136.2m (FY, 2017)
Gross profit
$154.1m (FY, 2016)
Gross profit
N/A
Gross profit
$30.7m (FY, 2017)
Net income
Net income
N/A
Net income
($67.9m) (FY, 2017)
Net income
$18.5m (FY, 2016)
Net income
($147.3m) (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 15.2m
Total funding raised
$ 70m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88m
For sources of this data, please see the company profileDownload Excel

View company profiles

Amarin
HQ
Dublin, IE
Employees
241↑ 12% increase

Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.

View company
Sucampo Pharmaceuticals
HQ
Rockville, US
Employees
139

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

View company
Array BioPharma
HQ
Boulder, US
Employees
209

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
263

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company